Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease

@article{Jia2016PulmonaryAE,
  title={Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease},
  author={Hongpeng Jia},
  journal={SHOCK},
  year={2016},
  volume={46},
  pages={239–248}
}
  • H. Jia
  • Published 1 September 2016
  • Medicine
  • SHOCK
ABSTRACT In response to infectious and, in some instances, noninfectious insults, the affected tissues/cells of the host undergo inflammation. However, uncontrolled inflammation could be detrimental to the host, resulting in inflammatory disease, such as inflammatory lung disease. Although the etiology of the disease is well defined, the underling pathogenesis is still incompletely understood. The renin–angiotensin system (RAS), one of the primary cardiovascular regulatory systems, has been… Expand

Paper Mentions

Observational Patient Registry Clinical Trial
Hypothesis: The apelin/APJ system is involved in the protection of the lung affected by the COVID-19 by interacting with the SARS-coV-2 entry door: the Angiotensin I Converting Enzyme 2… Expand
ConditionsCovid19
InterventionDiagnostic Test
Renin Angiotensin Aldosterone System in Pulmonary Fibrosis: Pathogenesis to Therapeutic Possibilities.
TLDR
The current understanding of the role of RAAS in lung fibrogenesis is reviewed, evidence on the anti-fibrotic actions of the newly recognized RAAS components (the ACE2/Ang-(1-7)/Mas axis and AT2 receptor) are provided, and potential strategies and translational efforts to convert this new knowledge into effective therapeutics for PF are discussed. Expand
Renin–Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome
TLDR
Targeting the renin–angiotensin system and reducing the pathogen’s cell entry could be a promising therapeutic strategy in the struggle against COVID-19. Expand
SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis
TLDR
It is hypothesize that the heptapeptide Ang1-7 could provide novel therapeutic interventions for pulmonary fibrosis patients and manage the imbalanced ACE/ACE2 axis. Expand
The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials
TLDR
Clinical trials are underway to test the risks and benefits of ARBs and angiotensin-converting enzyme inhibitors (ACEIs) in COVID-19 patients requiring hospitalization. Expand
Renin Angiotensin Aldosterone System Antagonism in 2019 Novel Coronavirus Acute Lung Injury
Abstract It has been established that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses angiotensin-converting enzyme 2 (ACE2), a membrane-bound regulatory peptide, for host cellExpand
The ACE2/Angiotensin-(1–7)/Mas Receptor Axis: Pleiotropic Roles in Cancer
TLDR
This review focuses on recent experimental and clinical studies investigating the basic properties, roles, and mechanisms of ACE2, Ang-(1–7), and the MasR, as well as the axis pathway, to provide insights into possible therapeutic strategies for treating cancer that target the ACE2/Ang-(1-7)/MasR axis. Expand
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
TLDR
The SARS-CoV-2 spike glycoprotein, which binds to ACE2, is a potential target for developing specific drugs, antibodies, and vaccines and Restoring the balance between the RAS and ACE2/angiotensin-(1–7)/MAS may help attenuate organ injuries. Expand
Renin-angiotensin system at the interface of COVID-19 infection
TLDR
Evidence demonstrates that ACEIs and ARBs, besides their cardioprotective effects in COVID-19 patients with cardiovascular diseases, might also be beneficial in acute lung injuries by preserving the ACE2 function and switching the balance from deleterious ACE/Ang II/AT1 receptor axis towards a protective ACE2/Ang (1–7)/Mas receptor axis. Expand
Angiotensin-converting enzyme 2 and COVID-19: patients, comorbidities, and therapies
TLDR
The evidence pertaining to ACE2’s relationship to common comorbidities, risk factors, and therapies associated with the susceptibility and severity of COVID-19 is reviewed and gaps of knowledge are highlighted that require further investigation. Expand
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic
TLDR
The relationship between COVID-19, neurodegenerative diseases, and ACE2 is reviewed, as well as recommendations for the protection of elderly patients with neurodegnerative diseases during the CO VID-19 pandemic are provided. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 145 REFERENCES
ACE and ACE2 in inflammation: a tale of two enzymes.
TLDR
Current understanding of the RAS components in inflammation is discussed, based on recent findings, on the role of ACE and ACE2 in inflammation. Expand
Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases
TLDR
Autoantibodies to ACE2 may be associated with constrictive vasculopathies, and immunosuppressive therapy given to one SLE patient with digital necrosis markedly decreased the anti-ACE2 antibody titer and restored serum ACE2 activity. Expand
Angiotensin-converting enzyme 2 protects from severe acute lung failure
TLDR
It is reported that ACE2 and the angiotensin II type 2 receptor (AT2) protect mice from severe acute lung injury induced by acid aspiration or sepsis, pointing to a possible therapy for a syndrome affecting millions of people worldwide every year. Expand
Nonclassical renin-angiotensin system and renal function.
  • M. Chappell
  • Biology, Medicine
  • Comprehensive Physiology
  • 2012
TLDR
Increasing evidence suggests that these non-classical RAS components contribute to the therapeutic blockade of the classical system to reduce blood pressure and attenuate various indices of renal injury, as well as contribute to normal renal function. Expand
[Serum and pulmonary angiotensin converting enzyme as a marker of acute lung injury in an experimental model of adult respiratory distress syndrome].
TLDR
The sequential determination of SACE has a prognostic and evolutive value in comparison with the LACE, which has a diagnostic value from the beginning of the experiment of ALI and maintained throughout. Expand
Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
TLDR
It is demonstrated that ACE2 plays a critical role in influenza A (H7N9) virus-induced acute lung injury, and suggested that might be a useful potential therapeutic target for future influenza A(H7n9) outbreaks. Expand
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
TLDR
The findings demonstrate the critical role of the kidney in the pathogenesis of hypertension and its cardiovascular complications and suggest that the major mechanism of action of RAS inhibitors in hypertension is attenuation of angiotensin II effects in the kidney. Expand
Upregulation of circulating components of the alternative renin-angiotensin system in inflammatory bowel disease: A pilot study
TLDR
Circulating components of the alternative RAS are increased in patients with IBD, and angiotensin (1-7) correlated weakly with platelet and white cell counts, but not calprotectin or CRP, in patientswith IBD. Expand
Novel roles of nuclear angiotensin receptors and signaling mechanisms.
TLDR
It is concluded that a functional intracellular or nuclear RAS may have important implications in the therapeutic approaches to cardiovascular disease. Expand
Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
TLDR
Endogenous ACE2 activation by DIZE has a preventive effect on LPS-induced ocular inflammation in the EIU mouse model and supports the notions that RAS plays a role in modulating ocular immune response and that enhancing ACE2 provides a novel therapeutic strategy for uveitis. Expand
...
1
2
3
4
5
...